(Q33909590)

29 July 2017

1 reference

title

Tamoxifen for relapse of ovarian cancer. (English)

1 reference

29 July 2017

Tamoxifen for relapse of ovarian cancer (English)

0 references

1 reference

1 reference

C J Williams

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2001

0 references

published in

1 reference

29 July 2017

CD001034

1 reference

29 July 2017

2

1 reference

Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report

29 July 2017

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001034

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001034

Osseous metaplasia in ovarian papillary serous cystadenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001034

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001034

Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001034

10.1002/14651858.CD001034

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference